Tcf7l1 Acts As a Suppressor for the Self-Renewal of Liver Cancer Stem Cells and is Regulated by IGF/MEK/ERK Signaling Independent of Β-Catenin.

Juanjuan Shan,Junjie Shen,Min Wu,Haijun Zhou,Juan Feng,Chao Yao,Zhi Yang,Qinghua Ma,Yanfeng Luo,Yuanliang Wang,Cheng Qian
DOI: https://doi.org/10.1002/stem.3063
IF: 5.845
2019-01-01
Stem Cells
Abstract:Tcf7l1, which is a key effector molecule of the Wnt/beta-catenin signaling pathway, is highly expressed in various cancers, and it promotes tumor growth. In this study, we demonstrated that unlike its tumor-promoting effects in several other types of cancers, Tcf7l1 expression is downregulated in hepatocarcinoma compared with their adjacent nontumor counterparts. Underexpression of Tcf7l1 is correlated with poorer survival. In liver cancer stem cell (CSC) populations, Tcf7l1 expression is downregulated. Ectopic expression of Tcf7l1 attenuates the self-renewal abilities of liver CSCs. Mechanistically, Tcf7l1 regulates the self-renewal abilities of liver CSCs through transcriptional repression of the Nanog gene, and the effect is independent of beta-catenin. Moreover, we found that Tcf7l1 expression is controlled by extracellular insulin-likegrowth factor (IGF) signaling, and we demonstrated for the first time that IGF signaling stimulates Tcf7l1 phosphorylation and degradation through the mitogen-activated protein kinase (MEK)/extracellularsignal-regulated kinase (ERK) pathway. Overall, our results provide some new insights into how extracellular signals modulate the self-renewal of liver CSCs and highlight the inhibitory roles of Tcf7l1 in cancer. Stem Cells 2019
What problem does this paper attempt to address?